Company Profile
Marinus Stock Price, News & Catalysts
- Ticker:
- MRNS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for MRNS.
Company overview
Business overview
Marinus is a neuroscience company focused on seizure and neuropsychiatric disorders with a commercial and development mix. Its story has been shaped by efforts to turn CNS programs into durable value.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Marinus sits in specialty neuroscience biopharma.
Business Model Characteristics
The business depends on product adoption, pipeline progress, and the ability to stabilize a concentrated CNS story.
Position Within the Biotechnology Landscape
Marinus is a catalyst-sensitive CNS name whose stock reacts to both commercial and clinical updates.
Future catalysts
- Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program. The story is now more about what the company becomes next than about a broad pipeline.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Marinus do?
Marinus is a neuroscience company focused on seizure and neuropsychiatric disorders with a commercial and development mix. Its story has been shaped by efforts to turn CNS programs into durable value.
On which exchange is MRNS stock listed?
Marinus (MRNS) is associated with NASDAQ, United States, Biopharma.
What is Marinus?
Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program.
Which conditions is Marinus targeting with Marinus?
Marinus is associated with neuroscience based on its company overview and current catalyst commentary.
How does Marinus describe recent progress with Marinus?
Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program.
What future catalysts are investors watching for Marinus?
Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program. The story is now more about what the company becomes next than about a broad pipeline.